ExLibris header image
 

SFX by Ex Libris Inc.

Contains information about title and source of a journal
Naslov: A phase I trial of palbociclib and bosutinib with fulvestrant in patients with metastatic hormone receptor positive and HER2 negative (HR+ HER2-) breast cancer refractory to an aromatase inhibitor and a CDK4/6 inhibitor
Vir:

Contemporary Clinical Trials Communications [2451-8654] Roy, Tina l. 2023, letn. 33, str. 101110

List of services to meet your request

Contains list of services for current record

Basic services

Celotno besedilo

service type icon, opens target in new window
Celotno besedilo dostopno v
Elsevier ScienceDirect Journals Complete
 
 
  Dostopnost: Oddaljen dostop za študente in zaposlene Univerze na Primorskem.

service type icon, opens target in new window
Celotno besedilo dostopno v
Elsevier ScienceDirect Journals Complete
 
 
  Dostopnost: Dostop je mogoč iz prostorov Univerze na Primorskem.

service type icon, opens target in new window
Celotno besedilo dostopno v
DOAJ_DIRECTORY_OPEN_ACCESS_JOURNALS
 
 

service type icon, opens target in new window
Celotno besedilo dostopno v
PubMed Central
 
 

service type icon, opens target in new window
Celotno besedilo dostopno v
ROAD: Directory of Open Access Scholarly Resources
 
 

Celotno besedilo

service type icon, opens target in new window
Celotno besedilo morda dostopno preko oznake
DOI


© 2024 SFX by Ex Libris Inc. | Piškotki
CrossRef Omogočeno